+44 (0) 20 3997 7634 | sales@fbkmed.com

Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.

Home > Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.

Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.

13/07/13

Latest Articles

Interim results for the six months ended 30 November 2022

07/02/23

Bleepa Feedback Medical Feedback PLC

Annual Results: New strategic direction delivers growth in Bleepa sales

20/09/22

Bleepa Feedback Medical Feedback PLC

Feedback awarded 12-month contract for pilot extension in Sussex CDC

06/09/22

Bleepa Feedback Medical Feedback PLC